Supplier News
Vetter Embarks on 300-Million Euro Manufacturing Expansion
October 1st 2015Vetter plans to invest approximately 300 million Euros during the course of five years to expand drug product manufacturing and logistic services in Germany; upgrades will include an improved RABS system for aseptic processing.
EMD Millipore Provides Risk-Assessment Information for Raw Materials
September 16th 2015EMD Millipore, the Life Science business of Merck KGaA, introduced expanded documentation and regulatory information for its Emprove portfolio of pharmaceutical raw materials, which include excipients, process chemicals, and APIs.
Recipharm and LobSor Pharmaceuticals Sign Manufacturing Agreement for Parkinson’s Treatment
September 8th 2015This agreement is a follow-on to an established collaboration between LobSor and Recipharm for the development and the manufacturing of Lecigon batches for the recently completed clinical trial.
Recipharm to Manufacture RedHill Biopharma’s FDC Therapy for Helicobacter pylori Infection
August 26th 2015Recipharm will be responsible for the supply of the remaining clinical-trial material and ongoing future commercial supply of RHB-105, the lead drug candidate developed by RedHill for the treatment of Helicobacter pylori bacterial infection.